Temperature-sensitive hydrogel for promoting wound healing as well as preparation method and application of temperature-sensitive hydrogel
By assembling carotenoids and ginsenosides with poloxamer 407 and dopamine, a temperature-sensitive hydrogel is formed, which solves the problem of existing hydrogels being unable to achieve temperature-sensitive and cell regeneration at the same time, and achieves the effect of accelerated wound healing and restoration of skin function. , suitable for patients with various wounds including diabetes.
Patent Information
- Application Number
- CN202411278196.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-09-12
AI Technical Summary
Existing hydrogels that promote wound healing cannot achieve both the ability to temperature sensitivity, remove free radicals and promote cell regeneration at wound sites.
Carotenoids and ginseng saponin are used as active ingredients and assembled with poloxamer 407, dopamine and poloxamer 188 under alkaline conditions to form a temperature-sensitive hydrogel, enhance cell repair and proliferation ability, and form a gel at body temperature. , enhance skin surface viscosity.
Accelerate the rate of wound healing and promote skin function recovery, especially the recovery of sebaceous glands and hair follicles, and is suitable for wound healing in normal and diabetic patients.
Smart Images

Figure CN118903165A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of auxiliary materials, and in particular to a thermosensitive hydrogel for promoting wound healing, and a preparation method and application thereof. Background Art
[0002] The skin is an important organ that covers the surface of the human body and is in direct contact with the external environment. It has the functions of sensing external stimuli, regulating body temperature, and protecting the human body from external harm. Due to its direct contact with the outside world, the skin has also become one of the most vulnerable tissues. Although most common skin injuries can be basically recovered within a period of time, it is difficult for adult skin injuries to restore skin function 100% like babies. This is usually accompanied by the formation of scar tissue and severe loss of skin appendages (such as hair, sweat glands, and sebaceous glands). The repair of skin wounds is divided into four continuous and coordinated processes: hemostasis, inflammation, proliferation, and remodeling. However, the wound healing process is usually not carried out perfectly and orderly. The influence of various factors at any stage may lead to abnormal wound repair, such as excessive inflammation, burns, or infection caused by large-area skin tissue loss, diabetic ulcers, etc.
[0003] Ion channels are macromolecular pores on the cell membrane that can be excited after being stimulated by external signals. They generally affect important physiological processes such as glandular secretion, muscle movement, cell division, and cell proliferation. Ion channels are recognized as the second largest category of drug targets in the field of global drug development. Calcium-activated chloride channels (CaCCs) are widely distributed in a variety of epithelial and non-epithelial tissues, and participate in many physiological processes. They can control and regulate ion dynamic balance, cell volume, cell excitability, sensory signal transduction, and transepithelial electrolyte transport. At the end of 2008, three independent research groups independently determined that transmembrane protein 16A (TMEM16A) was the coding gene of CaCCs channels using different methods. Currently, the National Center for Bioinformation (NCBI) in the United States can retrieve nearly 500 articles on TMEM16A, focusing on the tissue distribution, channel gating and permeability, association with signal transduction pathways, and extensive research on the relationship between this ion channel and cancer, hypertension, cystic fibrosis, gastrointestinal dysfunction, and especially the relationship with a variety of major diseases such as multiple types of cancer. It is worth noting that recent studies have shown that ion channels, especially TMEM16A channels, participate in regulating the proliferation of tail muscles and mesenchymal cells during the regeneration of the salamander's tail by mediating the p44 / 42MAPK-ERK1 / 2 signaling pathway. However, the molecular mechanism of TMEM16A regulating wound healing is still unclear.
[0004] In recent years, the research on new wound dressings has become more and more extensive, and many wound dressings have been developed to promote wound repair, such as semipermeable membranes, semipermeable foams, hydrocolloids, and hydrogels. Among them, hydrogels have become the most competitive candidate materials for wound dressings due to their good hydrophilicity and biocompatibility, and have also attracted the interest of many researchers. Research on hydrogels as wound dressings has also shown an increasing trend in the past decade. Many hydrophilic polymers, including natural polymers such as chitosan, gelatin, hyaluronic acid, alginate, and dextran, as well as synthetic hydrophilic polymers such as polyethylene glycol (PEG) and poloxamer, polyvinyl alcohol, olefin-containing polymerization monomers such as polyacrylamide (PAM), poly (acrylic acid) and polypeptides, have been used to construct hydrogels through various chemical or physical crosslinking. Among them, dynamic chemical bonding, photocrosslinking in situ polymerization, double network, semi-interpenetrating network, 3D printing, etc. all show good advantages. In addition, the function of hydrogels has also changed from a single physical coverage or a single function to the current combination of multiple functions, and it shows a trend of further intelligence.
[0005] Existing hydrogels that promote wound healing cannot simultaneously achieve the abilities of being thermosensitive, scavenging free radicals, and promoting the regeneration of cells at the wound site.
[0006] In view of this, the present invention is proposed. Summary of the invention
[0007] The purpose of the present invention is to provide a thermosensitive hydrogel for promoting wound healing and a preparation method and application thereof.
[0008] The present invention is achieved in that:
[0009] In a first aspect, the present invention provides a thermosensitive hydrogel for promoting wound healing, wherein the raw materials thereof include, by mass percentage, 0.1‰-1‰ of active ingredient, 1%-40% of poloxamer 407, 1%-10% of dopamine, 1%-20% of poloxamer 188, and the remainder of an alkaline solvent; the active ingredient includes at least one of carotenoids and ginsenosides.
[0010] In an optional embodiment, the carotenoid includes at least one of astaxanthin, canthaxanthin or lutein;
[0011] and / or, the ginsenosides include at least one of ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rg2, ginsenoside NGR1, ginsenoside Rf and ginsenoside Rh2;
[0012] And / or, the pH of the alkaline solvent is 8-9.
[0013] In a second aspect, the present invention provides a method for preparing a thermosensitive hydrogel for promoting wound healing as described in the aforementioned embodiment, comprising: mixing the raw materials uniformly.
[0014] In an optional embodiment, mixing the raw materials uniformly comprises:
[0015] Add the poloxamer 407 to the pre-cooled alkaline solvent and stir until clear;
[0016] Then add the active ingredient and continue stirring;
[0017] Then, the dopamine is added and stirred to allow the dopamine to self-polymerize under alkaline conditions to form an interpenetrating network with the poloxamer;
[0018] Finally, the poloxamer 188 is added to make the thermosensitive hydrogel for promoting wound healing liquid at room temperature and gel at body surface temperature.
[0019] In an optional embodiment, the viscosity of the thermosensitive hydrogel for promoting wound healing when in liquid form is 1 Pa·s-100 Pa·s.
[0020] In an optional embodiment, the thermosensitive hydrogel for promoting wound healing has a viscosity of 1500 Pa·s-2000 Pa·s when it is a gel.
[0021] In an optional embodiment, the mixing process of the raw materials is carried out at 3-5°C.
[0022] In a third aspect, the present invention provides a thermosensitive hydrogel for promoting wound healing as described in any of the aforementioned embodiments or a thermosensitive hydrogel for promoting wound healing prepared by the method for preparing a thermosensitive hydrogel for promoting wound healing as described in any of the aforementioned embodiments, and use thereof in the preparation of a medicament for promoting wound healing.
[0023] In an optional embodiment, the promoting wound healing includes promoting the reduction of wound area, promoting the recovery of skin function at the wound, and promoting the recovery of sebaceous glands and hair follicles in the wound.
[0024] In an alternative embodiment, the wound in which wound healing is promoted comprises a wound of a non-diabetic patient or a wound of a diabetic patient.
[0025] The present invention has the following beneficial effects:
[0026] The thermosensitive hydrogel for promoting wound healing provided by the present application, which uses at least one of carotenoids and ginsenosides as an active ingredient, is combined with poloxamer 407, dopamine, and poloxamer 188 under alkaline conditions to form an assembly, wherein carotenoids and ginsenosides have multiple biological activities and the ability to scavenge free radicals, and can promote cell repair, excite TMEM16A channels to promote cell proliferation, and assemble these two active ingredients with poloxamer and dopamine, increasing the solubility, bioavailability, biological activity and stability of these two active ingredients, thereby facilitating the wound healing rate, and the thermosensitive hydrogel for promoting wound healing provided by the present application forms a gel under body temperature (37°C), enhances the viscosity effect of the skin surface, is liquid at room temperature, and is easy to store and transport. The thermosensitive hydrogel for promoting wound healing provided by the present application can be widely used in the preparation of drugs for promoting wound healing, which is conducive to promoting the reduction of wound area, promoting the recovery of skin function at the wound, and promoting the recovery of sebaceous glands and hair follicles in the wound. The thermosensitive hydrogel for promoting wound healing provided in the present application can not only have a good healing effect on normal wounds, but also has a good healing effect on the wounds of diabetic patients. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.
[0028] Figure 1 This is a SEM schematic diagram of the thermosensitive hydrogel for promoting wound healing provided in Example 1 of the present application;
[0029] Figure 2 A schematic diagram of the transformation of the thermosensitive hydrogel for promoting wound healing provided in Example 1 of the present application between a liquid state and a gel state;
[0030] Figure 3 A graph showing how the complex viscosity of the thermosensitive hydrogel for promoting wound healing provided in Examples 1-3 of the present application changes with temperature;
[0031] Figure 4 A schematic diagram of the effects of different treatment groups on wound healing in mice provided in Experimental Example 1 of this application;
[0032] Figure 5 This is a schematic diagram of the difference analysis of wound area between different treatment groups on the wound healing effect on mice provided in Experimental Example 1 of this application;
[0033] Figure 6HE staining of the effects of different treatment groups on mouse wound healing provided in Experimental Example 1 of this application;
[0034] Figure 7 A schematic diagram of the effects of different treatment groups on the wound healing of rat backs provided in Experimental Example 2 of this application;
[0035] Figure 8 A schematic diagram of the difference analysis of wound area between different treatment groups on the wound healing effect on the back of rats provided in Experimental Example 2 of this application;
[0036] Fig. 9 HE staining of the effects of different treatment groups on wound healing on the back of rats provided in Experimental Example 2 of this application;
[0037] Fig.10 A schematic diagram of the effects of different treatment groups on the healing of rat foot wounds provided in Experimental Example 2 of this application;
[0038] Fig.11 A schematic diagram of the difference analysis of wound area between different treatment groups on the healing of rat foot wounds provided in Experimental Example 2 of this application;
[0039] Fig.12 HE staining diagram of the effects of different treatment groups on the healing of rat foot wounds provided in Experimental Example 2 of this application;
[0040] Fig.13 This is a schematic diagram of the effects of different treatment groups on wound healing in mice provided in Experimental Example 3 of this application;
[0041] Fig.14 A schematic diagram of the difference analysis of wound area between different treatment groups on the healing of infected wounds in mice provided in Experimental Example 3 of this application;
[0042] Fig.15 This is a HE staining image of the effects of different treatment groups on the healing of infected wounds in mice provided in Experimental Example 3 of this application. DETAILED DESCRIPTION
[0043] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.
[0044] The invention provides a thermosensitive hydrogel for promoting wound healing. The raw materials thereof include, by mass percentage, 0.1‰-1‰ active ingredient, 1%-40% of poloxamer 407, 1%-10% of dopamine, 1%-20% of poloxamer 188 and the remainder of an alkaline solvent.
[0045] The active ingredients include at least one of carotenoids and ginsenosides.
[0046] Carotenoids have multiple biological activities and the ability to scavenge free radicals. They have a high baseline antioxidant capacity and the ability to stimulate TMEM16A channels to promote cell proliferation. They have been approved by the FDA as a biologically active additive. However, carotenoids are not easily soluble in water and have a short residence time in the body, which limits their use. This application increases the solubility of carotenoids by assembling carotenoids with poloxamer and dopamine, and constructs a temperature-responsive hydrogel system so that it can form a gel at body temperature (37°C), enhance the viscosity effect on the skin surface, and be liquid at room temperature for easy storage and transportation. Specifically, carotenoids include at least one of astaxanthin, canthaxanthin or lutein.
[0047] Ginsenosides have the ability to promote cell repair and the ability to stimulate TMEM16A channels to promote cell proliferation. The present application helps to improve the bioavailability, biological activity and stability of ginsenosides by assembling ginsenosides with poloxamer and dopamine, and can regulate the release and delivery performance of ginsenosides. In addition, ginsenosides contain a large amount of phenolic hydroxyl groups, thereby improving the tissue adhesion of thermosensitive hydrogels that promote wound healing, significantly accelerating the wound healing rate, reducing immune inflammatory reactions, and increasing the generation of new proteins and pores. Specifically, ginsenosides include at least one of ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rg2, ginsenoside NGR1, ginsenoside Rf and ginsenoside Rh2. The pH of the alkaline solvent is 8-9. In the present application, an alkaline solvent is used to provide alkaline reaction conditions, which facilitates dopamine to self-polymerize under alkaline conditions and form an interpenetrating network with poloxamer.
[0048] The preparation method of the thermosensitive hydrogel for promoting wound healing comprises: mixing the raw materials evenly.
[0049] Specifically, the raw materials are mixed uniformly including the following steps:
[0050] S1. Add Poloxamer 407 to the pre-cooled alkaline solvent and stir until clear.
[0051] The alkaline solvent is prepared into an aqueous solution with a pH of 8-9 in advance, and the alkaline solvent is pre-cooled to 3-5°C, and then Poloxamer 407 is added and stirred overnight at 3-5°C until it is converted into a clear solution.
[0052] S2. Then add the active ingredient and continue stirring.
[0053] The active ingredient can be added directly or prepared into a suspension. When the suspension is prepared, it can be prepared directly using part of the alkaline solvent. The prepared suspension of the active ingredient is added to the solution of step S1 and stirred thoroughly overnight at 3-5°C.
[0054] S3. Then, dopamine is added and stirred to allow dopamine to self-polymerize under alkaline conditions to form an interpenetrating network with poloxamer.
[0055] S4. Finally, poloxamer 188 is added to make the thermosensitive hydrogel for promoting wound healing liquid at room temperature and gel at body surface temperature. The viscosity of the thermosensitive hydrogel for promoting wound healing liquid at room temperature, for example, 20-30° C., is 1 Pa·s-100 Pa·s, and the viscosity of the thermosensitive hydrogel for promoting wound healing gel is 1500 Pa·s-2000 Pa·s.
[0056] The thermosensitive hydrogel for promoting wound healing provided above can be widely used in the preparation of drugs for promoting wound healing. Among them, promoting wound healing includes promoting the reduction of wound area, promoting the recovery of skin function at the wound, and promoting the recovery of sebaceous glands and hair follicles in the wound. The wounds in promoting wound healing include wounds of non-diabetic patients or wounds of diabetic patients. That is, the thermosensitive hydrogel for promoting wound healing provided by the present application can not only have a good promoting healing effect on normal wounds, but also have a good promoting healing effect on the wounds of diabetic patients.
[0057] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.
[0058] Example 1
[0059] This embodiment provides a method for preparing a thermosensitive hydrogel for promoting wound healing, which comprises the following steps:
[0060] S1. Prepare NaOH in advance into an aqueous solution with a pH of 8-9 as an alkaline solvent, and precool the alkaline solvent to 4°C. Take 10 mL of the alkaline solvent, add 2 g of Poloxamer 407, and stir thoroughly overnight at 4°C until it becomes a clear solution.
[0061] S2. Prepare 0.1 mg of carotenoid (lutein) with a portion of alkaline solvent, add the prepared suspension of active ingredients to the solution of step S1, and stir thoroughly at 4°C overnight.
[0062] S3. Then, 50 mg of dopamine was added and stirred to allow dopamine to self-polymerize under alkaline conditions to form an interpenetrating network with poloxamer.
[0063] S4. Finally, 100 μL of Poloxamer 188 was added to make the thermosensitive hydrogel that promotes wound healing liquid at room temperature and gel at body surface temperature.
[0064] See also Figure 1 , Figure 2 , Figure 3 ,from Figure 1 It can be seen that the porous network structure of the composite hydrogel Figure 2-Figure 3 It can be seen that the thermosensitive hydrogel that promotes wound healing is liquid at room temperature. As the temperature rises, its viscosity increases significantly, and it is in a gel state at body surface temperature, which is beneficial to improving the adhesion of the thermosensitive hydrogel that promotes wound healing to the wound.
[0065] Example 2
[0066] This embodiment provides a method for preparing a thermosensitive hydrogel for promoting wound healing, which is basically the same as that of Embodiment 1, except that, in this embodiment, the amount of carotenoid used is 1‰.
[0067] The specific steps include:
[0068] S1. Prepare NaOH in advance into an aqueous solution with a pH of 8-9 as an alkaline solvent, and precool the alkaline solvent to 4°C. Take 10 mL of the alkaline solvent, add 2 g of Poloxamer 407, and stir thoroughly overnight at 4°C until it becomes a clear solution.
[0069] S2. Prepare 1 mg of carotenoid (lutein) with a portion of alkaline solvent, add the prepared suspension of active ingredients to the solution of step S1, and stir thoroughly at 4°C overnight.
[0070] S3. Then, 50 mg of dopamine was added and stirred to allow dopamine to self-polymerize under alkaline conditions to form an interpenetrating network with poloxamer.
[0071] S4. Finally, 100 μL of Poloxamer 188 was added to make the thermosensitive hydrogel that promotes wound healing liquid at room temperature and gel at body surface temperature.
[0072] Example 3
[0073] This embodiment provides a method for preparing a thermosensitive hydrogel for promoting wound healing, which is basically the same as that of Example 2, except that, in this embodiment, the carotenoid in Example 2 is replaced by ginsenoside Rb1.
[0074] The specific steps include:
[0075] S1. Prepare NaOH in advance into an aqueous solution with a pH of 8-9 as an alkaline solvent, and precool the alkaline solvent to 4°C. Take 10 mL of the alkaline solvent, add 2 g of Poloxamer 407, and stir thoroughly overnight at 4°C until it becomes a clear solution.
[0076] S2. Prepare 1 mg of ginsenoside Rb1 with a portion of alkaline solvent, add the prepared suspension of active ingredients into the solution of step S1, and stir thoroughly at 4°C overnight.
[0077] S3. Then, 50 mg of dopamine was added and stirred to allow dopamine to self-polymerize under alkaline conditions to form an interpenetrating network with poloxamer.
[0078] S4. Finally, 100 μL of Poloxamer 188 was added to make the thermosensitive hydrogel that promotes wound healing liquid at room temperature and gel at body surface temperature.
[0079] Comparative Example 1
[0080] This comparative example provides a hydrogel, which is basically the same as Example 1, except that this comparative example does not contain carotenoids, and the amount of carotenoids is replaced by an alkaline solvent. The specific preparation method is:
[0081] S1. Prepare NaOH in advance into an aqueous solution with a pH of 8-9 as an alkaline solvent, and precool the alkaline solvent to 4°C. Take 10 mL of the alkaline solvent, then add poloxamer 407, and stir thoroughly overnight at 4°C until it becomes a clear solution.
[0082] S2. Add 50 mg of dopamine and stir to allow dopamine to self-polymerize under alkaline conditions to form an interpenetrating network with poloxamer.
[0083] S3. Finally, add 100 μL of Poloxamer 188 to make the hydrogel liquid at room temperature and gel at body surface temperature.
[0084] Experimental Example 1: Effect of thermosensitive hydrogel on wound healing in mice
[0085] KM mice were selected to establish a wound model. Under anesthesia, a full-thickness skin injury with a diameter of 6 mm was prepared on the back skin of the mouse using a pore maker. After the wound was rinsed with normal saline, different treatments were given and divided into a control group (Control), a positive control group (hEGF gel, human epidermal growth factor gel, Guilin Huanovi Gene Pharmaceutical Co., Ltd.), a hydrogel group (Gel), Example 1 group (Gel C+low), Example 2 group (Gel C+high), and Example 3 group (Gel B).
[0086] Among them, the control group was treated with normal saline on the wound surface; the positive control group was treated with human epidermal growth factor gel on the wound surface once a day; the hydrogel group was treated with the carotenoid-free hydrogel provided in Comparative Example 1 on the wound surface; the Example 1 group, the Example 2 group, and the Example 3 group were treated with the thermosensitive hydrogel for promoting wound healing provided in Example 1, Example 2, and Example 3, respectively.
[0087] Each wound was wrapped with sterile gauze and fixed with elastic tape. The wound healing status was recorded with a digital camera on days 0, 3, 6, 9, and 12 after surgery, and the wound healing status was calculated using Image J software. Figure 4 and Figure 5 It was found that the positive control group and the high-concentration hydrogel Example 2 group showed good therapeutic effects starting from the third day, and then the low-concentration hydrogel Example 1 group and Example 3 group began to play a role. After 12 days of treatment, both Example 1 group (low concentration) and Example 3 group could achieve therapeutic effects comparable to the positive control, and the wound areas of Example 2 group (high concentration) and Example 3 group were smaller than those of the positive control.
[0088] See also Figure 6 Through HE staining, it was found that the wounds treated in Example 1, Example 2, and Example 3 recovered faster, the skin repair was more complete, and the sebaceous glands and pores on the wound surface were restored in structure and function.
[0089] Experimental Example 2: Effect of thermosensitive hydrogel on wound healing on back and foot wounds of diabetic rats
[0090] Healthy male SD rats aged 8 weeks were selected and routinely raised in an environment with a constant temperature of 22°C and a humidity of 55%. Under sterile conditions, type I diabetic rats were induced by a single intraperitoneal injection of 65 mg / kg streptozotocin (STZ). Rats with blood glucose exceeding 16.7 mmol / L after 1 week of administration were considered to have diabetes. A wound model was established. Under anesthesia, a pore was used to prepare a full-thickness skin injury with a diameter of 15 mm on the back skin of the rat and a full-thickness skin injury with a diameter of 8 mm on the dorsum of the right hind foot of the rat.
[0091] After the wound was rinsed with normal saline, different treatments were given and divided into a control group (Control), a positive control group (hEGFgel), a hydrogel group (Gel), Example 2 group (Gel+C), and a normal group (Normal, non-diabetic group). The wound healing status was recorded with a digital camera on days 0, 3, 6, 9, 12, and 15 after surgery, and the wound healing status was calculated using Image J software.
[0092] (1) Effect on back wound healing
[0093] See also Figure 7 and Figure 8 The experiment found that from the sixth day, the wound area of the rat skin in the Example 2 group and the positive control group was significantly smaller than that in the control group. After 15 days of treatment, the back wounds of the rats in the positive control group, Example 2 group and the normal group had basically healed, and the wound area was significantly different from that in the control group.
[0094] See also Fig. 9 Through HE staining, it was found that the wound area of the positive control group and Example 2 group was smaller, and the wound recovered more smoothly, and the sebaceous glands and hair follicles in the wound recovered faster than those in the control group. It is worth noting that after treatment, the number of sebaceous glands and hair follicles in the wound of Example 2 group was higher than that of the positive control group, which shows that Example 2 group is better in promoting the recovery of diabetic wounds.
[0095] (2) Effect on foot wound healing
[0096] See also Fig.10 and Fig.11 By giving different drugs, it was found that: on the 3rd day, all diabetic rats had varying degrees of redness and swelling on their foot wounds, while normal rats did not (the wound area was smaller than that of the control group); from the 6th day, the redness and swelling of the skin in the positive control group and Example 2 group subsided, and the wound area was significantly different from that in the control group; on the 15th day of treatment, compared with the control group, the wound area of the positive control group was significantly reduced, and the wound area of Example 2 group was significantly reduced. It is worth noting that Example 2 group is better than the positive control drug human epidermal growth factor gel in promoting diabetic foot skin. On the 9th, 12th, and 15th days, the wound area of Example 2 group was smaller than that of the positive control group.
[0097] See also Fig.12 HE staining revealed that only the sebaceous glands and hair follicles of the diabetic rat foot skin in the Example 2 group recovered significantly, while the other groups recovered slowly. And the recovery of the sebaceous glands and hair follicles in the Example 2 group was only slightly worse than that of the skin of normal rats. This shows that the treatment of the Example 2 group can not only make the diabetic foot wound heal faster, but more importantly, restore the skin function at the wound.
[0098] Experimental Example 3: Effect of thermosensitive hydrogel on wound healing of infected skin wounds in mice
[0099] Healthy male KM mice aged 6 weeks were selected and routinely raised in an environment with a constant temperature of 22°C and a humidity of 55%. An infected wound model was established. Under anesthesia, a full-thickness skin injury with a diameter of 8 mm was prepared on the back skin of the mouse using a pore maker. 100 microliters of activated Staphylococcus aureus liquid with an OD value of 1 was dripped into each wound. If the surrounding area of the wound begins to redden and swell within 48 hours, and the mouse screams in pain when pressed, and pus flows out of the wound, the surface wound is infected, and the inflammatory wound model is prepared.
[0100] Divided into a control group, a positive drug group and an experimental group, wherein the control group is a group without treatment, the positive drug group is a group coated with hEGF gel, human epidermal growth factor gel, Guilin Hua Nuowei Gene Pharmaceutical Co., Ltd., and the experimental group is a group coated with the drug provided in Example 2. The wound healing status was recorded with a digital camera on days 0, 3, 6, 9, and 12 after surgery, and the wound healing status was calculated using Image J software.
[0101] See also Fig.13 and Fig.14 The experiment found that within 6 days after the successful preparation of the inflammatory wound model, there was no significant difference in the healing rate of the three groups of mice, and the changes in wound area were basically the same; but after 6 days, the wound area of the experimental group mice was significantly reduced, and the wound healing rate was significantly different from the other two groups, while there was no significant difference between the control group and the positive drug group from beginning to end.
[0102] See also Fig.15 , HE staining revealed that due to the inflammatory reaction at the wound, subcutaneous tissue was not formed at the wound of the three groups of mice after 6 days of treatment. After 12 days of treatment, the epithelial tissue of the wounds of the three groups had been formed and separated from the scab. The epithelial healing of the positive drug group and the experimental group was smoother than that of the control group. Compared with the positive drug group, the number of fibroblasts around the wound in the experimental group increased significantly and the hair follicle function recovered more significantly. Therefore, the experimental group has a significant effect on promoting wound recovery in inflammatory wound healing, and can significantly promote epithelial cell repair and hair follicle regeneration, and its effect is better than that of the positive drug human epidermal growth factor gel.
[0103] In summary, the thermosensitive hydrogel for promoting wound healing provided by the present application uses at least one of carotenoids and ginsenosides as an active ingredient, and is combined with poloxamer 407, dopamine, and poloxamer 188 under alkaline conditions to form an assembly, wherein carotenoids and ginsenosides have multiple biological activities and the ability to scavenge free radicals, and can promote cell repair, excite TMEM16A channels and promote cell proliferation. The two active ingredients are assembled with poloxamer and dopamine, which increases the solubility, bioavailability, biological activity and stability of the two active ingredients, thereby helping to accelerate the wound healing rate, and the thermosensitive hydrogel for promoting wound healing provided by the present application forms a gel under body temperature (37°C), enhances the viscosity effect of the skin surface, and is liquid at room temperature for easy storage and transportation. The thermosensitive hydrogel for promoting wound healing provided by the present application can be widely used in the preparation of drugs for promoting wound healing, which is conducive to promoting the reduction of wound area, promoting the recovery of skin function at the wound, and promoting the recovery of sebaceous glands and hair follicles in the wound. The thermosensitive hydrogel for promoting wound healing provided in the present application can not only have a good healing effect on normal wounds, but also has a good healing effect on the wounds of diabetic patients and bacterially infected skin wounds.
[0104] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A thermosensitive hydrogel for promoting wound healing, characterized in that: The raw materials include, by mass percentage, 0.1‰-1‰ active ingredient, 1%-40% poloxamer 407, 1%-10% dopamine, 1%-20% poloxamer 188 and the remainder of an alkaline solvent; the active ingredient includes at least one of carotenoids and ginsenosides.
2. The thermosensitive hydrogel for promoting wound healing according to claim 1, characterized in that: The carotenoids include at least one of astaxanthin, canthaxanthin or lutein; and / or, the ginsenosides include at least one of ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rg2, ginsenoside NGR1, ginsenoside Rf and ginsenoside Rh2; And / or, the pH of the alkaline solvent is 8-9.
3. A method for preparing a thermosensitive hydrogel for promoting wound healing as claimed in claim 1, characterized in that: It includes: Mix the raw materials evenly.
4. The method for preparing the thermosensitive hydrogel for promoting wound healing according to claim 3, characterized in that: Mixing the raw materials uniformly comprises: Add the poloxamer 407 to the pre-cooled alkaline solvent and stir until clear; Then add the active ingredient and continue stirring; Then, the dopamine is added and stirred to allow the dopamine to self-polymerize under alkaline conditions to form an interpenetrating network with the poloxamer; Finally, the poloxamer 188 is added to make the thermosensitive hydrogel for promoting wound healing liquid at room temperature and gel at body surface temperature.
5. The method for preparing the thermosensitive hydrogel for promoting wound healing according to claim 4, characterized in that: The viscosity of the thermosensitive hydrogel for promoting wound healing when in liquid form is 1 Pa·s-100 Pa·s.
6. The method for preparing the thermosensitive hydrogel for promoting wound healing according to claim 4, characterized in that: The viscosity of the thermosensitive hydrogel for promoting wound healing when in the form of a gel is 1500 Pa·s-2000 Pa·s.
7. The method for preparing the thermosensitive hydrogel for promoting wound healing according to claim 4, characterized in that: The characteristic is that the mixing process of the raw materials is carried out at 3-5°C.
8. Use of the thermosensitive hydrogel for promoting wound healing as claimed in any one of claims 1 to 3 or the method for preparing the thermosensitive hydrogel for promoting wound healing as claimed in any one of claims 4 to 7 in preparing a medicament for promoting wound healing.
9. The use according to claim 8, characterized in that: The promotion of wound healing includes promoting the reduction of wound area, promoting the recovery of skin function at the wound, and promoting the recovery of sebaceous glands and hair follicles in the wound.
10. The use according to claim 8, characterized in that: The wounds in which wound healing is promoted include wounds of non-diabetic patients or wounds of diabetic patients.
Citation Information
Patent Citations
Temperature-sensitive hydrogel drug delivery system, preparation method and application
CN114848814A
Preparation method and application of temperature-sensitive hydrogel
CN115969772A
Epidermal growth factor / polydopamine-MXene temperature-sensitive hydrogel as well as preparation method and application thereof
CN117959486A
Hydrogel, pharmaceutical composition comprising same, and application thereof
WO2019241985A1
